Melanoma & Skin Cancer | Specialty

The OncLive Melanoma & Skin Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of skin cancers, including melanoma, basal cell carcinoma, and more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in melanoma and other skin cancers.

Intralesional Combinations Pave the Way for Melanoma Treatment

October 18th 2017

The use of intralesional therapies in combination with checkpoint inhibitors has shown to be an improvement to monotherapy and combinations with immunotherapy in melanoma.

Dr. Luke on Impactful Data in the Field of Melanoma

October 10th 2017

Jason Luke, MD, an assistant professor of medicine at the University of Chicago Medicine, discusses impactful data in the field of melanoma.

Advances in Treating Melanoma: Closing Thoughts

October 3rd 2017

COMBI-AD: Dual-Targeted Therapy for Stage 3 Melanoma

October 3rd 2017

The Role of Lymphadenectomy in Node-Positive Melanoma

October 3rd 2017

Locoregional Therapy for Advanced Melanoma

October 3rd 2017

Alternative Approaches to Treating Melanoma

October 3rd 2017

Emerging Agents and Combinations for Advanced Melanoma

October 3rd 2017

Considering Chemotherapy's Value in Melanoma

October 3rd 2017

Sequencing Therapies in BRAF Wild-Type Melanoma

October 3rd 2017

Melanoma: Mechanisms of Resistance to Therapy

October 3rd 2017

Targeting NRAS Mutations in Metastatic Melanoma

October 3rd 2017

Data in Melanoma: Observing Trials and Unmet Needs

October 3rd 2017

Choosing the Right Therapy for Melanoma

October 3rd 2017

Managing Brain Metastases in Melanoma

October 3rd 2017

The Value of Ipi/Nivo in Treating Metastatic Melanoma

October 3rd 2017

Metastatic Melanoma: The Immunotherapy Approach

October 3rd 2017

Expert Addresses Ongoing Challenges in Melanoma

October 3rd 2017

Merrick I. Ross, MD, discusses ongoing challenges in melanoma, including treating liver metastases, the diminished yet important role of surgery, and the need for better biomarkers.

Dr. Postow on Combination Regimens for High-Risk Melanoma

September 28th 2017

Michael A. Postow, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses combinations of regimens for patients with high-risk melanoma.

Dr. Weber on CheckMate-238 Compared With Other Trials in Melanoma

September 28th 2017

Jeffrey S. Weber, MD, PhD, deputy director and co-director of the Melanoma Program at the Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, discusses the results of CheckMate-238 compared with other adjuvant trials for patients with melanoma.